Ann-Margaret Asher
Nurse Practitioner · Pasadena, CANPI 1447375712
Payments from drug & device makers
Across 171 payments — averaging $22.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$584
- GSK$389
- Novo Nordisk$373
- Lilly USA, LLC$346
- Sanofi Pasteur Inc.$341
- Abbott$292
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,769100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $584 |
| GSK | 15 | $389 |
| Novo Nordisk | 19 | $373 |
| Lilly USA, LLC | 15 | $346 |
| Sanofi Pasteur Inc. | 14 | $341 |
| Abbott | 13 | $292 |
| Bausch Health US, LLC | 12 | $257 |
| AstraZeneca | 10 | $208 |
| Boehringer Ingelheim | 6 | $157 |
| Amgen | 8 | $142 |
| Exact Sciences | 6 | $136 |
| Merck | 5 | $113 |
| Boston Scientific | 3 | $74 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $70 |
| Hologic Sales And Service, LLC | 3 | $60 |
| Pfizer | 2 | $53 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Phadia US Inc. | 2 | $37 |
| Corcept Therapeutics | 1 | $29 |
| Intra-sana Laboratories | 1 | $21 |
| Shield Therapeutics Inc | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
How this compares
$3,769 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SynthroidLevothyroxine Sodium | 15 | $1,400 |
| Atorvastatin Calcium | 61 | $554 |
| Amlodipine Besylate | 39 | $422 |
| Levothyroxine Sodium | 30 | $268 |
| Lisinopril | 44 | $257 |
| Rosuvastatin Calcium | 15 | $215 |
| Metoprolol Succinate | 11 | $190 |
| Metformin Hcl | 22 | $167 |
| Omeprazole | 15 | $164 |
| Gabapentin | 20 | $141 |
| Allopurinol | 11 | $125 |
| Pantoprazole Sodium | 13 | $79 |
| Losartan Potassium | 14 | $72 |
| Triamcinolone Acetonide | 14 | $68 |
| Temazepam | 11 | $66 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $584 | $1,40015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,779 nurse practitioner providers in California.
Other nurse practitioner in Pasadena
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.